Evaluating ibrutinib in the treatment of symptomatic Waldenstrom's macroglobulinemia
about
Evaluating ibrutinib in the treatment of symptomatic Waldenstrom's macroglobulinemia
description
scientific article published on 27 August 2019
@en
name
Evaluating ibrutinib in the treatment of symptomatic Waldenstrom's macroglobulinemia
@en
type
label
Evaluating ibrutinib in the treatment of symptomatic Waldenstrom's macroglobulinemia
@en
prefLabel
Evaluating ibrutinib in the treatment of symptomatic Waldenstrom's macroglobulinemia
@en
P2093
P356
P1476
Evaluating ibrutinib in the treatment of symptomatic Waldenstrom's macroglobulinemia
@en
P2093
Aristea-Maria Papanota
Efstathios Kastritis
Ioannis Ntanasis-Stathopoulos
Meletios A Dimopoulos
P304
P356
10.2147/JBM.S183997
P577
2019-08-27T00:00:00Z